Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis.
Casini A, Alberio L, Angelillo-Scherrer A, Fontana P, Gerber B, Graf L, Hegemann I, Korte W, Kremer Hovinga J, Lecompte T, Martinez M, Nagler M, Studt JD, Tsakiris D, Wuillemin W, Asmis L. Casini A, et al. Among authors: hegemann i. Swiss Med Wkly. 2020 Apr 11;150:w20247. doi: 10.4414/smw.2020.20247. eCollection 2020 Apr 6. Swiss Med Wkly. 2020. PMID: 32277760 Free article. No abstract available.
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland.
Alberio L, Angelillo-Scherrer A, Asmis L, Casini A, Fontana P, Graf L, Hegemann I, Kremer Hovinga JA, Korte W, Lecompte T, Martinez M, Nagler M, Studt JD, Tsakiris DA, Wuillemin W. Alberio L, et al. Among authors: hegemann i. Swiss Med Wkly. 2020 Apr 24;150:w20210. doi: 10.4414/smw.2020.20210. eCollection 2020 Apr 20. Swiss Med Wkly. 2020. PMID: 32329806 Free article.
Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab.
Fontana P, Alberio L, Albisetti M, Angelillo-Scherrer A, Asmis LM, Casini A, Gerber B, Graf L, Hegemann I, Korte W, Martinez M, Studt JD, Tsakiris DA, Wuillemin WA, Kremer Hovinga JA. Fontana P, et al. Among authors: hegemann i. Swiss Med Wkly. 2020 Dec 18;150:w20422. doi: 10.4414/smw.2020.20422. eCollection 2020 Dec 14. Swiss Med Wkly. 2020. PMID: 33338252 Free article.
Daratumumab for immune thrombotic thrombocytopenic purpura.
van den Berg J, Kremer Hovinga JA, Pfleger C, Hegemann I, Stehle G, Holbro A, Studt JD. van den Berg J, et al. Among authors: hegemann i. Blood Adv. 2022 Feb 8;6(3):993-997. doi: 10.1182/bloodadvances.2021005124. Blood Adv. 2022. PMID: 34551063 Free PMC article.
Daratumumab in rituximab-refractory autoimmune haemolytic anaemia.
Rieger MJ, Stolz SM, Ludwig S, Benoit TM, Bissig M, Widmer CC, Schwotzer R, Müller AM, Nair G, Hegemann I, Manz MG, Schanz U. Rieger MJ, et al. Among authors: hegemann i. Br J Haematol. 2021 Sep;194(5):931-934. doi: 10.1111/bjh.17655. Epub 2021 Jun 28. Br J Haematol. 2021. PMID: 34180543 No abstract available.
A pilot clinical phase II trial MemSID: Acute and durable changes of red blood cells of sickle cell disease patients on memantine treatment.
Mahkro A, Hegemann I, Seiler E, Simionato G, Claveria V, Bogdanov N, Sasselli C, Torgerson P, Kaestner L, Manz MG, Goede JS, Gassmann M, Bogdanova A. Mahkro A, et al. Among authors: hegemann i. EJHaem. 2020 May 20;1(1):23-34. doi: 10.1002/jha2.11. eCollection 2020 Jul. EJHaem. 2020. PMID: 35847705 Free PMC article.
25 results